Menu

News & Insights

  • Clear

State AGs Pen EpiPen Settlements With Mylan

Maryland AG Anthony Brown and North Carolina AG Jeff Jackson announced separate settlements with Mylan resolving allegations that the company used anticompetitive tactics to maintain EpiPen’s market dominance and drive up prices for the life-saving allergy medication. According to the AGs’ offices, Mylan allegedly suppressed generic competition through exclusionary contracts with pharmacy benefit managers, delayed…

Read More

Iowa Demands Change Over Data Breach Fallout

Iowa AG Brenna Bird filed a lawsuit against healthcare claims clearinghouse Change Healthcare Inc. and its owners and operators alleging that cybersecurity and breach-response failures during a 2024 cyberattack violated the Iowa Consumer Fraud Act and the Personal Information Security Breach Protection Act. The petition claims the companies used outdated, insecure systems that lacked basic…

Read More

FTC Announces New Healthcare Task Force

FTC Chairman Andrew N. Ferguson issued a memorandum directing agency staff to form a Healthcare Task Force aimed at coordinating healthcare enforcement and advocacy across the FTC. According to the memorandum, the Task Force will bring together staff from the FTC’s competition, consumer protection, and economics bureaus, along with the Offices of Policy Planning and…

Read More

Louisiana AG Reaches $45 Million Settlement with CVS over Alleged PBM Misconduct

Louisiana AG Liz Murrill reached a $45 million settlement with CVS Health Corp. and its pharmacy benefit manager (PBM) subsidiary to resolve three lawsuits alleging deceptive and anti-competitive practices that allegedly violated the Louisiana Unfair Trade Practices Act. According to the AG’s office, the settlement resolves allegations that CVS improperly used customer information to conduct…

Read More

FTC Lands Landmark Settlement with Express Scripts over Insulin Rebate Practices

The FTC reached a settlement with Express Scripts, Inc. and its affiliates (collectively “Express Scripts”) to resolve an administrative lawsuit alleging the pharmacy benefit manager violated Section 5 of the FTC Act by artificially inflating insulin prices.

Read More